Clal Biotechnology | CBI - EPS Earnings Per Share

Stock Price
31.90
Daily Change
1.00 3.24%
Monthly
5.63%
Yearly
5.28%
Q2 Forecast
29.98

Clal Biotechnology reported ILS-0.04 in EPS Earnings Per Share for its fiscal quarter ending in December of 2022.





Eps Change Date
Arca Biopharma USD -0.54 0.14 Dec/2025
aTyr Pharma USD 0.53 0.8 Dec/2025
Bio Path USD -0.07 0.48 Sep/2025
Brainstorm Cell Therapeutics USD -0.19 0.15 Sep/2025
Cara Therapeutics USD -0.59 4.45 Sep/2025
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD 0.59 0.67 Dec/2025
Immunic USD -0.24 0.03 Sep/2024
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
Minerva Neurosciences USD -0.56 3.53 Dec/2024
RedHill Biopharma USD -1.31 33.38 Jun/2024
TherapeuticsMD USD -0.09 0.02 Jun/2024